Last 12 months
Inside the activity.
0 purchase rows · 169 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 23 |
| Dec 2025 | 0 | 18 |
| Jan 2026 | 0 | 44 |
| Feb 2026 | 0 | 22 |
| Mar 2026 | 0 | 8 |
| Apr 2026 | 0 | 10 |
| May 2026 | 0 | 19 |
| Jun 2026 | 0 | 13 |
| Jul 2026 | 0 | 7 |
| Aug 2026 | 0 | 4 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 17, 2023 Filed May 17, 2023 20:11 UTC |
Lewis WilliamDirector · Chair and CEO
|
SaleCommon Stock | 7,099 | $18.12 | $128,633.88 |
DisclosureSEC source: 0001628280-23-018684 · wf-form4_168435429831173.xml · nonDerivative · entry 3 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 341,345 F1 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees. F3 · price: This is a weighted average sales price representing 7,099 shares sold at prices ranging from $18.12 to $18.13 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| May 17, 2023 Filed May 17, 2023 20:07 UTC |
Adsett RogerChief Operating Officer
|
SaleCommon Stock | 2,448 | $18.12 | $44,357.76 |
DisclosureSEC source: 0001628280-23-018673 · wf-form4_168435404211099.xml · nonDerivative · entry 3 Adsett Roger · CIK 0001685904 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 160,333 F1 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees. Read SEC document |
| May 16, 2023 Filed May 17, 2023 20:16 UTC |
Wise John DraytonChief Commercial Officer
|
SaleCommon Stock | 381 | $18.44 | $7,025.64 |
DisclosureSEC source: 0001628280-23-018700 · wf-form4_168435453768194.xml · nonDerivative · entry 2 Wise John Drayton · CIK 0001930805 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 107,960 F1 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees. Read SEC document |
| May 16, 2023 Filed May 17, 2023 20:13 UTC |
Schaeffer Orlov S NicoleChief People Strategy Officer
|
SaleCommon Stock | 1,217 | $18.45 | $22,453.65 |
DisclosureSEC source: 0001628280-23-018691 · wf-form4_168435436955097.xml · nonDerivative · entry 2 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 95,497 F1 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees. Read SEC document |
| May 16, 2023 Filed May 17, 2023 20:14 UTC |
Smith Michael AlexanderGeneral Counsel, Senior VP
|
SaleCommon Stock | 475 | $18.43 | $8,754.25 |
DisclosureSEC source: 0001628280-23-018696 · wf-form4_168435443742523.xml · nonDerivative · entry 2 Smith Michael Alexander · CIK 0001870278 · General Counsel, Senior VP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,345 F1 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees. F3 · price: This is the weighted average sales price representing 475 shares sold at prices ranging from $18.40 to $18.45 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| May 16, 2023 Filed May 17, 2023 20:11 UTC |
Lewis WilliamDirector · Chair and CEO
|
SaleCommon Stock | 3,714 | $18.41 | $68,374.74 |
DisclosureSEC source: 0001628280-23-018684 · wf-form4_168435429831173.xml · nonDerivative · entry 2 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 348,444 F1 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees. Read SEC document |
| May 16, 2023 Filed May 17, 2023 20:09 UTC |
Bonstein SaraChief Financial Officer
|
SaleCommon Stock | 1,610 | $18.47 | $29,736.70 |
DisclosureSEC source: 0001628280-23-018679 · wf-form4_168435416317222.xml · nonDerivative · entry 2 Bonstein Sara · CIK 0001604019 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 117,619 F1 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees. Read SEC document |
| May 16, 2023 Filed May 17, 2023 20:10 UTC |
Flammer Martina M.D.Chief Medical Officer
|
SaleCommon Stock | 1,718 | $18.43 | $31,662.74 |
DisclosureSEC source: 0001628280-23-018681 · wf-form4_168435423354522.xml · nonDerivative · entry 2 Flammer Martina M.D. · CIK 0001796960 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 114,906 F1 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees. F3 · price: This is the weighted average sales price representing 1,718 shares sold at prices ranging from $18.43 to $18.47 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| May 16, 2023 Filed May 17, 2023 20:07 UTC |
Adsett RogerChief Operating Officer
|
SaleCommon Stock | 1,521 | $18.39 | $27,971.19 |
DisclosureSEC source: 0001628280-23-018673 · wf-form4_168435404211099.xml · nonDerivative · entry 2 Adsett Roger · CIK 0001685904 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 162,781 F1 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees. Read SEC document |
| May 15, 2023 Filed May 17, 2023 20:16 UTC |
Wise John DraytonChief Commercial Officer
|
SaleCommon Stock | 593 | $19.29 | $11,438.97 |
DisclosureSEC source: 0001628280-23-018700 · wf-form4_168435453768194.xml · nonDerivative · entry 1 Wise John Drayton · CIK 0001930805 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 108,341 F1 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees. F2 · price: This is the weighted average sales price representing 593 shares sold at prices ranging from $19.29 to $19.30 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| May 15, 2023 Filed May 17, 2023 20:13 UTC |
Schaeffer Orlov S NicoleChief People Strategy Officer
|
SaleCommon Stock | 1,830 | $19.22 | $35,172.60 |
DisclosureSEC source: 0001628280-23-018691 · wf-form4_168435436955097.xml · nonDerivative · entry 1 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 96,714 F1 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees. Read SEC document |
| May 15, 2023 Filed May 17, 2023 20:14 UTC |
Smith Michael AlexanderGeneral Counsel, Senior VP
|
SaleCommon Stock | 1,897 | $19.24 | $36,498.28 |
DisclosureSEC source: 0001628280-23-018696 · wf-form4_168435443742523.xml · nonDerivative · entry 1 Smith Michael Alexander · CIK 0001870278 · General Counsel, Senior VP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,820 F1 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees. F2 · price: This is the weighted average sales price representing 1,897 shares sold at prices ranging from $19.24 to $19.26 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| May 15, 2023 Filed May 17, 2023 20:11 UTC |
Lewis WilliamDirector · Chair and CEO
|
SaleCommon Stock | 6,048 | $19.23 | $116,303.04 |
DisclosureSEC source: 0001628280-23-018684 · wf-form4_168435429831173.xml · nonDerivative · entry 1 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 352,158 F1 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees. F2 · price: This is a weighted average sales price representing 6,048 shares sold at prices ranging from $19.21 to $19.24 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| May 15, 2023 Filed May 17, 2023 20:09 UTC |
Bonstein SaraChief Financial Officer
|
SaleCommon Stock | 2,210 | $19.30 | $42,653.00 |
DisclosureSEC source: 0001628280-23-018679 · wf-form4_168435416317222.xml · nonDerivative · entry 1 Bonstein Sara · CIK 0001604019 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 119,229 F1 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees. F2 · price: This is the weighted average sales price representing 2,210 shares sold at prices ranging from $19.29 to $19.32 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| May 15, 2023 Filed May 17, 2023 20:10 UTC |
Flammer Martina M.D.Chief Medical Officer
|
SaleCommon Stock | 2,576 | $19.28 | $49,665.28 |
DisclosureSEC source: 0001628280-23-018681 · wf-form4_168435423354522.xml · nonDerivative · entry 1 Flammer Martina M.D. · CIK 0001796960 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 116,624 F1 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees. F2 · price: This is the weighted average sales price representing 2,576 shares sold at prices ranging from $19.27 to $19.28 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| May 15, 2023 Filed May 17, 2023 20:07 UTC |
Adsett RogerChief Operating Officer
|
SaleCommon Stock | 2,847 | $19.27 | $54,861.69 |
DisclosureSEC source: 0001628280-23-018673 · wf-form4_168435404211099.xml · nonDerivative · entry 1 Adsett Roger · CIK 0001685904 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 164,302 F1 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees. F2 · price: This is the weighted average sales price representing 2,847 shares sold at prices ranging from $19.26 to $19.28 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| May 15, 2023 Filed May 17, 2023 20:06 UTC |
SHAROKY MELVIN MDDirector
|
PurchaseCommon Stock | 10,000 | $19.29 | $192,900.00 |
DisclosureSEC source: 0001628280-23-018666 · wf-form4_168435394565987.xml · nonDerivative · entry 2 SHAROKY MELVIN MD · CIK 0001182633 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Padonia, LLC Disclosed balance after: 10,000 F2 · price: This is the weighted average purchase price representing 10,000 shares purchased at prices ranging from $19.22 to $19.34 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares purchased at each price within the price range upon request. F3 · ownership.nature: The Reporting Person is the managing member of Padonia, LLC. Read SEC document |
| May 15, 2023 Filed May 17, 2023 20:06 UTC |
SHAROKY MELVIN MDDirector
|
PurchaseCommon Stock | 10,000 | $19.29 | $192,900.00 |
DisclosureSEC source: 0001628280-23-018666 · wf-form4_168435394565987.xml · nonDerivative · entry 1 SHAROKY MELVIN MD · CIK 0001182633 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 298,615 F1 · price: This is the weighted average purchase price representing 10,000 shares purchased at prices ranging from $19.22 to $19.35 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares purchased at each price within the price range upon request. Read SEC document |
| May 12, 2023 Filed May 15, 2023 20:12 UTC |
Lewis WilliamDirector · Chair and CEO
|
Exercise / conversionStock Option · Derivative | 83,333 | $12.44 Strike: $12.44 | $1,036,662.52 |
DisclosureSEC source: 0001628280-23-018171 · wf-form4_168418150462788.xml · derivative · entry 8 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By ARTICLE 4 KATIE PROCTER DYNASTY TRUST Disclosed balance after: 0 Underlying: Common Stock · 83,333 shares Expires 2023-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: twenty five percent (25%) vested on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable. Read SEC document |
| May 12, 2023 Filed May 15, 2023 20:12 UTC |
Lewis WilliamDirector · Chair and CEO
|
Exercise / conversionStock Option (right to buy) · Derivative | 83,334 | $12.44 Strike: $12.44 | $1,036,674.96 |
DisclosureSEC source: 0001628280-23-018171 · wf-form4_168418150462788.xml · derivative · entry 7 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By ARTICLE 4 TRUST UNDER KATIE PROCTER DYNASTY TRUST Disclosed balance after: 0 Underlying: Common Stock · 83,334 shares Expires 2023-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: twenty five percent (25%) vested on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable. Read SEC document |
| May 12, 2023 Filed May 15, 2023 20:12 UTC |
Lewis WilliamDirector · Chair and CEO
|
Exercise / conversionStock Option (right to buy) · Derivative | 67,257 | $12.44 Strike: $12.44 | $836,677.08 |
DisclosureSEC source: 0001628280-23-018171 · wf-form4_168418150462788.xml · derivative · entry 6 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By ARTICLE 4 TRUST UNDER KATIE PROCTER DYNASTY TRUST Disclosed balance after: 0 Underlying: Common Stock · 67,257 shares Expires 2023-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: twenty five percent (25%) vested on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable. Read SEC document |
| May 12, 2023 Filed May 15, 2023 20:12 UTC |
Lewis WilliamDirector · Chair and CEO
|
Exercise / conversionCommon Stock | 83,334 | $12.44 | $1,036,674.96 |
DisclosureSEC source: 0001628280-23-018171 · wf-form4_168418150462788.xml · nonDerivative · entry 4 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · Indirect Disclosed balance after: 233,924 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · ownership.nature: By ARTICLE 4 TRUST UNDER KATIE PROCTER DYNASTY TRUST, of which the reporting person is a trustee. The reporting person and members of the reporting person's immediate family are the sole beneficiaries of the trust. Read SEC document |
| May 12, 2023 Filed May 15, 2023 20:12 UTC |
Lewis WilliamDirector · Chair and CEO
|
Exercise / conversionCommon Stock | 83,333 | $12.44 | $1,036,662.52 |
DisclosureSEC source: 0001628280-23-018171 · wf-form4_168418150462788.xml · nonDerivative · entry 3 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · Indirect Disclosed balance after: 150,590 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · ownership.nature: By ARTICLE 4 TRUST UNDER KATIE PROCTER DYNASTY TRUST, of which the reporting person is a trustee. The reporting person and members of the reporting person's immediate family are the sole beneficiaries of the trust. Read SEC document |
| May 12, 2023 Filed May 15, 2023 20:12 UTC |
Lewis WilliamDirector · Chair and CEO
|
Exercise / conversionCommon Stock | 67,257 | $12.44 | $836,677.08 |
DisclosureSEC source: 0001628280-23-018171 · wf-form4_168418150462788.xml · nonDerivative · entry 2 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · Indirect Disclosed balance after: 67,257 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · ownership.nature: By ARTICLE 4 TRUST UNDER KATIE PROCTER DYNASTY TRUST, of which the reporting person is a trustee. The reporting person and members of the reporting person's immediate family are the sole beneficiaries of the trust. Read SEC document |
| May 11, 2023 Filed May 15, 2023 20:25 UTC |
SCHAFER CAROLDirector
|
GrantCommon Stock | 13,192 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-23-018209 · wf-form4_168418233227543.xml · nonDerivative · entry 1 SCHAFER CAROL · CIK 0001272181 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,097 F1 · shares: Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock. The Restricted Stock Units have a one year cliff vesting period, provided that the director (a) remains a member of the Board on such vesting date, and (b) attends at least 75% of the meetings of the Board which take place between the grant date and the first anniversary of the grant date. Vested shares are delivered within 30 days of the vesting date. F2 · price: Each Restricted Stock Unit was granted on May 11, 2023, for no consideration. Read SEC document |
| May 11, 2023 Filed May 15, 2023 20:27 UTC |
SHAROKY MELVIN MDDirector
|
GiftCommon Stock | 1,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-018211 · wf-form4_168418241982699.xml · nonDerivative · entry 2 SHAROKY MELVIN MD · CIK 0001182633 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 288,615 Read SEC document |
| May 11, 2023 Filed May 15, 2023 20:27 UTC |
SHAROKY MELVIN MDDirector
|
GrantCommon Stock | 13,192 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-23-018211 · wf-form4_168418241982699.xml · nonDerivative · entry 1 SHAROKY MELVIN MD · CIK 0001182633 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 290,415 F1 · shares: Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock. The Restricted Stock Units have a one year cliff vesting period, provided that the director (a) remains a member of the Board on such vesting date, and (b) attends at least 75% of the meetings of the Board which take place between the grant date and the first anniversary of the grant date. Vested shares are delivered within 30 days of the vesting date. F2 · price: Each Restricted Stock Unit was granted on May 11, 2023, for no consideration. Read SEC document |
| May 11, 2023 Filed May 15, 2023 20:24 UTC |
MCGIRR DAVID W JDirector
|
GrantCommon Stock | 13,192 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-23-018207 · wf-form4_168418226315938.xml · nonDerivative · entry 1 MCGIRR DAVID W J · CIK 0001219023 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 85,753 F1 · shares: Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock. The Restricted Stock Units have a one year cliff vesting period, provided that the director (a) remains a member of the Board on such vesting date, and (b) attends at least 75% of the meetings of the Board which take place between the grant date and the first anniversary of the grant date. Vested shares are delivered within 30 days of the vesting date. F2 · price: Each Restricted Stock Unit was granted on May 11, 2023, for no consideration. Read SEC document |
| May 11, 2023 Filed May 15, 2023 20:23 UTC |
LEE LEODirector
|
GrantCommon Stock | 13,192 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-23-018205 · wf-form4_168418220866282.xml · nonDerivative · entry 1 LEE LEO · CIK 0001740789 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 111,457 F1 · shares: Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock. The Restricted Stock Units have a one year cliff vesting period, provided that the director (a) remains a member of the Board on such vesting date, and (b) attends at least 75% of the meetings of the Board which take place between the grant date and the first anniversary of the grant date. Vested shares are delivered within 30 days of the vesting date. F2 · price: Each Restricted Stock Unit was granted on May 11, 2023, for no consideration. Read SEC document |
| May 11, 2023 Filed May 15, 2023 20:22 UTC |
Desjardins ClarissaDirector
|
GrantCommon Stock | 13,192 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-23-018201 · wf-form4_168418215072198.xml · nonDerivative · entry 1 Desjardins Clarissa · CIK 0001793390 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,787 F1 · shares: Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock. The Restricted Stock Units have a one year cliff vesting period, provided that the director (a) remains a member of the Board on such vesting date, and (b) attends at least 75% of the meetings of the Board which take place between the grant date and the first anniversary of the grant date. Vested shares are delivered within 30 days of the vesting date. F2 · price: Each Restricted Stock Unit was granted on May 11, 2023, for no consideration. Read SEC document |
| May 11, 2023 Filed May 15, 2023 20:21 UTC |
Brennan David RDirector
|
GrantCommon Stock | 13,192 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-23-018200 · wf-form4_168418208788013.xml · nonDerivative · entry 1 Brennan David R · CIK 0001609305 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 108,713 F1 · shares: Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock. The Restricted Stock Units have a one year cliff vesting period, provided that the director (a) remains a member of the Board on such vesting date, and (b) attends at least 75% of the meetings of the Board which take place between the grant date and the first anniversary of the grant date. Vested shares are delivered within 30 days of the vesting date. F2 · price: Each Restricted Stock Unit was granted on May 11, 2023, for no consideration. Read SEC document |
| May 11, 2023 Filed May 15, 2023 20:20 UTC |
ANDERSON ELIZABETH MDirector
|
GrantCommon Stock | 13,192 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-23-018198 · wf-form4_168418201428060.xml · nonDerivative · entry 1 ANDERSON ELIZABETH M · CIK 0001758247 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,509 F1 · shares: Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock. The Restricted Stock Units have a one year cliff vesting period, provided that the director (a) remains a member of the Board on such vesting date, and (b) attends at least 75% of the meetings of the Board which take place between the grant date and the first anniversary of the grant date. Vested shares are delivered within 30 days of the vesting date. F2 · price: Each Restricted Stock Unit was granted on May 11, 2023, for no consideration. Read SEC document |
| May 11, 2023 Filed May 15, 2023 20:19 UTC |
ALTOMARI ALFREDDirector
|
GrantCommon Stock | 13,192 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-23-018193 · wf-form4_168418195780663.xml · nonDerivative · entry 1 ALTOMARI ALFRED · CIK 0001285644 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,333 F1 · shares: Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock. The Restricted Stock Units have a one year cliff vesting period, provided that the director (a) remains a member of the Board on such vesting date, and (b) attends at least 75% of the meetings of the Board which take place between the grant date and the first anniversary of the grant date. Vested shares are delivered within 30 days of vesting date. F2 · price: Each Restricted Stock Unit was granted on May 11, 2023, for no consideration. Read SEC document |
| May 11, 2023 Filed May 15, 2023 20:15 UTC |
Wise John DraytonChief Commercial Officer
|
GrantStock Option (right to buy) · Derivative | 146,220 | $0.00 Strike: $18.95 | $0.00 |
DisclosureSEC source: 0001628280-23-018183 · wf-form4_168418171156141.xml · derivative · entry 2 Wise John Drayton · CIK 0001930805 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 146,220 Underlying: Common Stock · 146,220 shares Expires 2033-05-11 F3 · derivative.exercise_date: Stock options granted under the Company's 2019 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary date of the date of grant. Read SEC document |
| May 11, 2023 Filed May 15, 2023 20:15 UTC |
Wise John DraytonChief Commercial Officer
|
GrantCommon Stock | 31,662 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-23-018183 · wf-form4_168418171156141.xml · nonDerivative · entry 1 Wise John Drayton · CIK 0001930805 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 108,934 F1 · shares: Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the date of grant. F2 · price: Each Restricted Stock Unit was received as a grant on May 11, 2023, for no consideration. Read SEC document |
| May 11, 2023 Filed May 15, 2023 20:14 UTC |
Smith Michael AlexanderGeneral Counsel, Senior VP
|
GrantStock Option (right to buy) · Derivative | 121,850 | $0.00 Strike: $18.95 | $0.00 |
DisclosureSEC source: 0001628280-23-018180 · wf-form4_168418166701360.xml · derivative · entry 2 Smith Michael Alexander · CIK 0001870278 · General Counsel, Senior VP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 121,850 Underlying: Common Stock · 121,850 shares Expires 2033-05-11 F3 · derivative.exercise_date: Stock options granted under the Company's 2019 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. Read SEC document |
| May 11, 2023 Filed May 15, 2023 20:14 UTC |
Smith Michael AlexanderGeneral Counsel, Senior VP
|
GrantCommon Stock | 26,385 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-23-018180 · wf-form4_168418166701360.xml · nonDerivative · entry 1 Smith Michael Alexander · CIK 0001870278 · General Counsel, Senior VP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,717 F1 · shares: Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the date of grant. F2 · price: Each Restricted Stock Unit was received as a grant on May 11, 2023, for no consideration. Read SEC document |
| May 11, 2023 Filed May 15, 2023 20:13 UTC |
Schaeffer Orlov S NicoleChief People Strategy Officer
|
GrantStock Option (right to buy) · Derivative | 121,850 | $0.00 Strike: $18.95 | $0.00 |
DisclosureSEC source: 0001628280-23-018174 · wf-form4_168418156777258.xml · derivative · entry 2 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 121,850 Underlying: Common Stock · 121,850 shares Expires 2033-05-11 F3 · derivative.exercise_date: Stock options granted under the Company's 2019 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary date of the date of grant. Read SEC document |
| May 11, 2023 Filed May 15, 2023 20:13 UTC |
Schaeffer Orlov S NicoleChief People Strategy Officer
|
GrantCommon Stock | 26,385 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-23-018174 · wf-form4_168418156777258.xml · nonDerivative · entry 1 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 98,544 F1 · shares: Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the date of grant. F2 · price: Each Restricted Stock Unit was received as a grant on May 11, 2023, for no consideration. Read SEC document |
| May 11, 2023 Filed May 15, 2023 20:12 UTC |
Lewis WilliamDirector · Chair and CEO
|
GrantStock Option (right to buy) · Derivative | 430,140 | $0.00 Strike: $18.95 | $0.00 |
DisclosureSEC source: 0001628280-23-018171 · wf-form4_168418150462788.xml · derivative · entry 5 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 430,140 Underlying: Common Stock · 430,140 shares Expires 2033-05-11 F4 · derivative.exercise_date: Stock options granted under the Company's 2019 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary date of the date of grant. Read SEC document |
| May 11, 2023 Filed May 15, 2023 20:12 UTC |
Lewis WilliamDirector · Chair and CEO
|
GrantCommon Stock | 93,139 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-23-018171 · wf-form4_168418150462788.xml · nonDerivative · entry 1 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 358,206 F1 · shares: Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the date of grant. F2 · price: Each Restricted Stock Unit was received as a grant on May 11, 2023, for no consideration. Read SEC document |
| May 11, 2023 Filed May 15, 2023 20:10 UTC |
Flammer Martina M.D.Chief Medical Officer
|
GrantStock Option (right to buy) · Derivative | 146,220 | $0.00 Strike: $18.95 | $0.00 |
DisclosureSEC source: 0001628280-23-018167 · wf-form4_168418140031650.xml · derivative · entry 3 Flammer Martina M.D. · CIK 0001796960 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 146,220 Underlying: Common Stock · 146,220 shares Expires 2033-05-11 F4 · derivative.exercise_date: Stock options granted under the Company's 2019 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary date of the date of the grant. Read SEC document |
| May 11, 2023 Filed May 15, 2023 20:10 UTC |
Flammer Martina M.D.Chief Medical Officer
|
GrantCommon Stock | 14,775 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-23-018167 · wf-form4_168418140031650.xml · nonDerivative · entry 2 Flammer Martina M.D. · CIK 0001796960 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 119,200 F3 · shares: Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: one third on each anniversary of the date of grant through the third anniversary date of the date of grant. F2 · price: Each Restricted Stock Unit was received as a grant on May 11, 2023, for no consideration. Read SEC document |
| May 11, 2023 Filed May 15, 2023 20:10 UTC |
Flammer Martina M.D.Chief Medical Officer
|
GrantCommon Stock | 31,662 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-23-018167 · wf-form4_168418140031650.xml · nonDerivative · entry 1 Flammer Martina M.D. · CIK 0001796960 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 104,425 F1 · shares: Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the date of the grant. F2 · price: Each Restricted Stock Unit was received as a grant on May 11, 2023, for no consideration. Read SEC document |
| May 11, 2023 Filed May 15, 2023 20:08 UTC |
Bonstein SaraChief Financial Officer
|
GrantCommon Stock · Derivative | 158,410 | $0.00 Strike: $18.95 | $0.00 |
DisclosureSEC source: 0001628280-23-018160 · wf-form4_168418128865059.xml · derivative · entry 3 Bonstein Sara · CIK 0001604019 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 158,410 Underlying: Common Stock · 158,410 shares Expires 2033-05-11 F4 · derivative.exercise_date: Stock options granted under the Company's 2019 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary date of the date of grant. Read SEC document |
| May 11, 2023 Filed May 15, 2023 20:08 UTC |
Bonstein SaraChief Financial Officer
|
GrantCommon Stock | 21,108 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-23-018160 · wf-form4_168418128865059.xml · nonDerivative · entry 2 Bonstein Sara · CIK 0001604019 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 121,439 F3 · shares: Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: one third on each anniversary of the date of grant through the third anniversary date of the date of the grant. F2 · price: Each Restricted Stock Unit was received as a grant on May 11, 2023, for no consideration. Read SEC document |
| May 11, 2023 Filed May 15, 2023 20:08 UTC |
Bonstein SaraChief Financial Officer
|
GrantCommon Stock | 34,300 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-23-018160 · wf-form4_168418128865059.xml · nonDerivative · entry 1 Bonstein Sara · CIK 0001604019 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,331 F1 · shares: Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the date of the grant. F2 · price: Each Restricted Stock Unit was received as a grant on May 11, 2023, for no consideration. Read SEC document |
| May 11, 2023 Filed May 15, 2023 20:06 UTC |
Adsett RogerChief Operating Officer
|
GrantCommon Stock · Derivative | 146,220 | $0.00 Strike: $18.95 | $0.00 |
DisclosureSEC source: 0001628280-23-018152 · wf-form4_168418117556876.xml · derivative · entry 2 Adsett Roger · CIK 0001685904 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 146,220 Underlying: Common Stock · 146,220 shares Expires 2033-05-11 F3 · derivative.exercise_date: Stock options granted under the Company's 2019 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary date of the date of grant. Read SEC document |
| May 11, 2023 Filed May 15, 2023 20:06 UTC |
Adsett RogerChief Operating Officer
|
GrantCommon Stock | 31,662 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-23-018152 · wf-form4_168418117556876.xml · nonDerivative · entry 1 Adsett Roger · CIK 0001685904 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 167,149 F1 · shares: Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the date of the grant. F2 · price: Each Restricted Stock Unit was received as a grant on May 11, 2023, for no consideration. Read SEC document |
| March 15, 2023 Filed Mar 17, 2023 20:11 UTC |
SHAROKY MELVIN MDDirector
|
GiftCommon Stock | 3,798 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-23-012309 · form4.xml · nonDerivative · entry 1 SHAROKY MELVIN MD · CIK 0001182633 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 277,223 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.